New insights into patterns of first metastatic sites influencing survival of patients with hormone receptor-positive, HER2-negative breast cancer: a multicenter study of 271 patients

BACKGROUND: The initial therapeutic strategy for hormone receptor-positive (HR+), HER2-negative (HER2-) breast cancer is based on the first metastatic site; however, little evidence is available regarding the influence of metastatic distribution patterns of first metastatic sites on prognosis. In th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamura, Jun, Kamigaki, Shunji, Fujita, Junya, Osato, Hiroki, Manabe, Hironobu, Tanaka, Yumiko, Shinzaki, Wataru, Hashimoto, Yukihiko, Komoike, Yoshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086318/
https://www.ncbi.nlm.nih.gov/pubmed/33926418
http://dx.doi.org/10.1186/s12885-021-08219-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086318/
https://www.ncbi.nlm.nih.gov/pubmed/33926418
http://dx.doi.org/10.1186/s12885-021-08219-3

Ejemplares similares